RHEACELL GmbH & Co. KG
PrivateLast Round
Corporate Funding
Jul 30, 2020
Total Funding Raised
$70.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RHEACELL GmbH & Co. KG is a biopharmaceutical company that develops innovative stem cell-based therapies for severe immune and inflammation-driven diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RHEACELL GmbH & Co. KG Comparables
Compare RHEACELL GmbH & Co. KG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Castle Creek Biosciences | 74% | |
| Abeona Therapeutics Inc. | 74% | |
| Longeveron | 74% |
RHEACELL GmbH & Co. KG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 30, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 68% MoM, reaching 2.5K.
- May 23, 2026
Grew 21% QoQ, from 67 to 81 employees.
RHEACELL GmbH & Co. KG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RHEACELL GmbH & Co. KG's valuation, stock price, and market status.
Is RHEACELL GmbH & Co. KG a public or private company?
RHEACELL GmbH & Co. KG is a private company.
What is the current stock price of RHEACELL GmbH & Co. KG?
RHEACELL GmbH & Co. KG is a private company with no public stock price. No recent secondary market data is available.
How much is RHEACELL GmbH & Co. KG worth (valuation)?
Valuation information for RHEACELL GmbH & Co. KG is not publicly available.
Can I buy RHEACELL GmbH & Co. KG stock?
RHEACELL GmbH & Co. KG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RHEACELL GmbH & Co. KG's last funding round?
RHEACELL GmbH & Co. KG's most recent funding round was Corporate Funding on July 30, 2020.
Who are the main investors in RHEACELL GmbH & Co. KG?
Investor information for RHEACELL GmbH & Co. KG is not publicly disclosed.
Will RHEACELL GmbH & Co. KG IPO soon?
No public IPO plans have been announced for RHEACELL GmbH & Co. KG.
How can I track RHEACELL GmbH & Co. KG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RHEACELL GmbH & Co. KG's secondary market activity and sign up for updates.